Identification of the rat homologue of KAI1 and its expression in dunning rat prostate cancers

Prostate

Volumn 37, Issue 4, 1998, Pages 253-260

  Suzuki, Hiroyoshi ^a   Dong, Jin Tang ^b   Gao, Allen Chuan ^a   Barrett, J Carl ^c   Isaacs, John T ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Dunning tumors; KAI1; Metastasis suppressor gene; Prostate cancer

Indexed keywords

MEMBRANE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL MODEL; ARTICLE; DNA LIBRARY; DNA PROBE; GENE EXPRESSION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; SEQUENCE HOMOLOGY; SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; BASE SEQUENCE; DNA, COMPLEMENTARY; FORECASTING; HUMANS; KANGAI-1 PROTEIN; MALE; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS; RATS; REFERENCE VALUES; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED;

EID: 0031758519     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19981201)37:4<253::AID-PROS7>3.0.CO;2-3     Document Type: Article

References (30)

1. Ichikawa T, Ichikawa Y, Dong JT, Hawkins AL, Griffin CA, Isaacs WB, Oshimura M, Barrett JC, Isaacs JT: Localization of metastasis suppressor gene(s) for prostate cancer to the short arm of human chromosome 11. Cancer Res 1992;52:3486-3490.
2. Rinker-Schaeffer CW, Hawkins AL, Ru N, Dong JT, Stoice G, Griffin CA, Ichikawa T, Barrett JC, Isaacs JT: Differential suppression of mammary and prostate cancer metastasis by human chromosome 17 and 11. Cancer Res 1994;54:6249-6256.
3. Dong J-T, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC: KAI1, a metastasis, suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995;268:884-886.
4. Kawana Y, Komiya A, Ueda T, Nihei N, Kuramochi H, Suzuki H, Yatani R, Imai T, Dong J-T, Imai T, Yoshie O, Barrett JC, Isaacs JT, Shimazaki J, Ito H, Ichikawa T: Location of KAI1 on the short arm of human chromosome 11 and frequency of allelic loss in advanced human prostate cancer. Prostate 1997;32:205-213.
5. Gao AC, Lou W, Dong J-T, Isaacs JT: CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res 1997;57:846-849.
6. Dong J-T, Suzuki H, Pin SS, Bova GS, Schalken JA, Issacs WB, Barrett JC, Isaacs JT: Downregulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res 1996;56:4387-4390.
7. Adachi M, Taki T, Ieki Y, Huang C-L, Higashiyama M, Miyake M: Correlation of KSI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 1996;56:1751-1755.
8. Wei LL, Yang X, Phillips K, Weissman BE, Welch DR: Analysis of KAI-1 mRNA expression in human breast cancer cell lines. Proc Am Assoc Cancer Res 1996;37:76.
9. Guo X, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Korc M, Buchler MW: KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res 1996;56:4876-4880.
10. Yu Y, Yang J-L, Markovic B, Jackson P, Yardley G, Barrett J, Russell PJ: Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers. Clin Cancer Res 1997;3:1045-1049.
11. Isaacs JT, Feitz WB, Scheres J: Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic ability of prostatic cancer. Prostate 1986;9:261-281.
12. Imai T, Fukudome K, Takagi S, Nagira M, Furuse M, Fukuhara N, Nishimura M, Hinuma Y, Yoshie O: C33 antigen recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J Immunol 1992;149:2879-2886.
13. Isaacs JT, Hukku B: Nonrandom involvement of chromosome 4 in the progression of rat prostatic cancer. Prostate 1988;13:165-188.
14. Isaacs JT: The R-3327 system of rat prostatic cancers. Urol Oncol 1996;2:115-116.
15. Frohman MA, Dush MK, Martin GR: Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci USA 1988;85:8998-9002.
16. Kyte J, Doolittle RF: A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982;157:105-132.
17. Fukudome K, Furuse M, Imai T, Nishimura M, Takagi S, Hinuma Y, Yoshie O: Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation; altered glycosylation of C33 antigen in HTLV-1-positive T cells. J Virol 1992;66:1394-1404.
18. Hotta H, Ross AH, Heubner K, Isobe M, Wendeborn S, Chao MV, Ricciardi RP, Tsujimoto Y, Croce CM, Koprowski H: Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res 1988;48:2955-2962.
19. Kondoh M, Ueda M, Ichihashi M, Mishima Y: Decreased expression of human melanoma-associated antigen ME491 along the progression of melanoma pre-cancerouses to invasive and metastatic melanomas. Melanoma Res 1993;3:241-245.
20. Metzelaar MJ, Wijngaard PL, Peters PJ, Sixma JJ, Nieuwenhuis HK, Clevers HC: CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 1991;266:3239-3245.
21. Miyake M, Koyama M, Seno M, Ikeyama S: Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med 1991;174: 1347-1354.
22. Boucheix C, Benoit P, Frachet P, Billard M, Worthington RE, Gagnon J, Uzan G: Molecular cloning of the CD9 antigen. A new family of cell surface proteins. J Biol Chem 1991;266:117-122.
23. Oren R, Takahashi S, Doss C, Levy R, Levy S: TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol 1990;10:4007-4015.
24. Levy S, Nguyen VQ, Andria ML, Takahashi S: Structure and membrane topology of TAPA-1. J Biol Chem 1991;266:14597-14602.
25. Classon AF, Williams AF, Willis AC, Seed B, Stamenkovic I: The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J Exp Med 1989; 169:1497-1502.
26. Amiot M: Identification and analysis of cDNA clones encoding CD53. A pan-leukocyte antigen related to membrane transport proteins. J Immunol 1990;145:4322-4325.
27. Miyake M, Nakao K, Ieki Y, Adachi M, Huang C-L, Itoi S, Koh T, Taki T: Mortality related protein 1 (MRP-1/CD9) expression: Inverse correlation with metastases in breast cancer. Cancer Res 1995;55:4127-4131.
28. Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS: Beta 1-6 branching Asn-linked oligosaccharides is directly associated with metastasis. Science 1987;236:582-585.
29. Ishikawa M, Dennis JW, Man S, Kerbel RS: Isolation and characterization of spontaneous wheat germ agglutinin-resistant human melanoma mutants displaying remarkably different metastatic profiles in nude mice. Cancer Res 1988;48:665-670.
30. Ueda T, Ichikawa T, Tamaru J-I, Mikata A, Akakura K, Akimoto S, Imai T, Yoshie O, Shiraishi T, Yatani R, Ito H, Shimazaki J: Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer. Am J Pathol 1996;149:1435-1440.